会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • LOW DOSE NO DONOR-CONTAINING TRANSDERMAL PATCH
    • 低剂量不含复合透皮贴片
    • WO2007092284A3
    • 2008-07-03
    • PCT/US2007002835
    • 2007-02-02
    • CURE THERAPEUCTICS INCANG ROBERTJACOBSON SVENWEIMANN LUDWIG
    • ANG ROBERTJACOBSON SVENWEIMANN LUDWIG
    • A61F13/02A61F13/00
    • A61K9/7061A61K31/21A61K47/10
    • The present invention is drawn to a transdermal patch for the delivery of a nitroglycerin or other NO donor. The patch can comprise a backing layer, and a nitroglycerin-containing composition or other NO donor-containing composition which is supported at least in part by the backing layer. The transdermal patch can have a drug delivery zone defined by the area where the composition contacts an intact human skin site, and the transdermal patch can be formulated to deliver a nitric oxide donor, such as nitroglycerin, at from about 5 µg/hour to about 70 µg/hour. In one embodiment, the transdermal patch can provide a delivery rate at the drug delivery zone of from about 1 µg/cm2/day to about 600 µg/cm2/day. In another embodiment, the transdermal patch can contain from 6 wt% to 18 wt% of the nitric oxide donor, e.g., nitroglycerin. In each embodiment, the patch can contain at least 450 µg/cm2 of nitroglycerin.
    • 本发明涉及用于递送硝酸甘油或其他NO供体的透皮贴片。 贴剂可以包含背衬层和含硝酸甘油的组合物或至少部分由背衬层支撑的含NO供体的组合物。 透皮贴剂可以具有由组合物接触完整的人皮肤部位的区域限定的药物递送区,并且透皮贴剂可以配制成以约5μg/小时至约约1μg/小时递送一氧化氮供体,例如硝酸甘油 70μg/小时。 在一个实施方案中,透皮贴剂可以在药物递送区域提供约1μg/ cm 2 /天至约600μg/ cm 2 /天的递送速率。 在另一个实施方案中,透皮贴剂可含有6重量%至18重量%的一氧化氮供体,例如硝酸甘油。 在每个实施方案中,贴剂可含有至少450μg/ cm 2的硝酸甘油。
    • 9. 发明申请
    • LOW DOSE NO DONOR-CONTAINING TRANSDERMAL PATCH
    • 低剂量不含复合透皮贴片
    • WO2007092284A2
    • 2007-08-16
    • PCT/US2007/002835
    • 2007-02-02
    • CURE THERAPEUCTICS, INC.ANG, RobertJACOBSON, SvenWEIMANN, Ludwig
    • ANG, RobertJACOBSON, SvenWEIMANN, Ludwig
    • A61K9/70A61K31/21
    • A61K9/7061A61K31/21A61K47/10
    • The present invention is drawn to a transdermal patch for the delivery of a nitroglycerin or other NO donor. The patch can comprise a backing layer, and a nitroglycerin-containing composition or other NO donor-containing composition which is supported at least in part by the backing layer. The transdermal patch can have a drug delivery zone defined by the area where the composition contacts an intact human skin site, and the transdermal patch can be formulated to deliver a nitric oxide donor, such as nitroglycerin, at from about 5 μg/hour to about 70 μg/hour. In one embodiment, the transdermal patch can provide a delivery rate at the drug delivery zone of from about 1 μg/cm2/day to about 600 μg/cm2/day. In another embodiment, the transdermal patch can contain from 6 wt% to 18 wt% of the nitric oxide donor, e.g., nitroglycerin. In each embodiment, the patch can contain at least 450 μg/cm2 of nitroglycerin.
    • 本发明涉及用于递送硝酸甘油或其他NO供体的透皮贴片。 贴剂可以包含背衬层和含硝酸甘油的组合物或至少部分由背衬层支撑的含NO供体的组合物。 透皮贴剂可以具有由组合物接触完整的人皮肤部位的区域限定的药物递送区域,并且可以配制透皮贴片,以约5μg/小时至约约5μg/小时递送一氧化氮供体,例如硝酸甘油 70μg/小时。 在一个实施方案中,透皮贴剂可以在药物递送区域提供约1μg/ cm 2 /天至约600μg/ cm 2 /天的递送速率。 在另一个实施方案中,透皮贴剂可含有6重量%至18重量%的一氧化氮供体,例如硝酸甘油。 在每个实施方案中,贴剂可含有至少450μg/ cm 2的硝酸甘油。